Precision Lung Cancer Survivorship Care Intervention

Launched by JEROD L STAPLETON, PHD · May 4, 2023

Keywords

ClinConnect Summary

The Precision Lung Cancer Survivorship Care Intervention is a clinical trial aimed at improving the quality of life for lung cancer survivors. Researchers are testing a new program called the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) to see how well it helps people who have survived lung cancer compared to standard care, which includes reading materials and assessments. The study will involve 300 participants, and its goal is to help survivors feel better, reduce the stigma associated with lung cancer, and encourage them to engage more actively in their follow-up care.

To be eligible for this trial, participants must have been diagnosed with lung cancer, live in a rural area, and be at least 18 years old. They should also be able to communicate effectively in English. However, individuals with serious mental health issues, substance abuse problems, or those already involved in another similar program cannot participate. For those who join, they can expect to receive support and resources tailored to help them navigate life after lung cancer treatment, ultimately aiming to enhance their well-being and connect them with necessary care services.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have been diagnosed with lung cancer
• • Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
• • Be at least 18 years of age or older
• • Be able to communicate effectively in English
• Exclusion Criteria:
• • Have significant psychiatric disturbance that requires a higher level of care
• • Have substance abuse/dependence that requires a higher level of care
• • Are participating in another lung cancer survivorship care intervention
• • Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program